Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 20

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Linking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures

Hajam, Irshad Ahmed, Liu, George Y. · 2024 · Antibiotics

Abstract

Vaccination arguably remains the only long-term strategy to limit the spread of S. aureus infections and its related antibiotic resistance. To date, however, all staphylococcal vaccines tested in clinical trials have failed. In this review, we propose that the failure of S. aureus vaccines is intricately linked to prior host exposure to S. aureus and the pathogen’s capacity to evade adaptive immune defenses. We suggest that non-protective immune imprints created by previous exposure to S. aureus are preferentially recalled by SA vaccines, and IL-10 induced by S. aureus plays a unique role in shaping these non-protective anti-staphylococcal immune responses. We discuss how S. aureus modifies the host immune landscape, which thereby necessitates alternative approaches to develop successful staphylococcal vaccines.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/antibiotics13050410

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 87

  1. Chatzakis, 2011, Infant colonization by Staphylococcus aureus: Role of maternal carriage, Eur. J. Clin. Microbiol. Infect. Dis., 30, 1111, 10.1007/s10096-011-1199-9 · DOI
  2. Sakr, A., Brégeon, F., Mège, J.L., Rolain, J.M., and Blin, O. (2018). Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections. Front. Microbiol., 9. · DOI · Paper page
  3. Wright, 1902, Notes on the Treatment of Furunculosis, Sycosis, and Acne by the Inoculation of a Staphylococcus aureus Vaccine, Lancet, 159, 874, 10.1016/S0140-6736(01)83603-5 · doi:10.1016/s0140-6736(01)83603-5
  4. Missiakas, 2016, Staphylococcus aureus vaccines: Deviating from the carol, J. Exp. Med., 213, 1645, 10.1084/jem.20160569 · DOI
  5. Clegg, 2021, Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies, Front. Immunol., 12, 705360, 10.3389/fimmu.2021.705360 · DOI · Paper page
  6. Armentrout, E.I., Liu, G.Y., and Martins, G.A. (2020). T Cell Immunity and the Quest for Protective Vaccines against Staphylococcus aureus Infection. Microorganisms, 8. · DOI
  7. Miller, 2020, Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms, FEMS Microbiol. Rev., 44, 123, 10.1093/femsre/fuz030 · DOI · Paper page
  8. Tsai, 2022, Non-protective immune imprint underlies failure of Staphylococcus aureus IsdB vaccine, Cell Host Microbe, 30, 1163, 10.1016/j.chom.2022.06.006 · DOI
  9. Howden, 2023, nature reviews microbiology Staphylococcus aureus host interactions and adaptation, Nat. Rev. Microbiol., 21, 380, 10.1038/s41579-023-00852-y · DOI · Paper page
  10. Goldmann, 2018, Staphylococcus aureus strategies to evade the host acquired immune response, Int. J. Med. Microbiol., 308, 625, 10.1016/j.ijmm.2017.09.013 · DOI
  11. Sharara, 2021, Decolonization of Staphylococcus aureus, Infect. Dis. Clin. N. Am., 35, 107, 10.1016/j.idc.2020.10.010 · DOI
  12. Vanegas, 2021, Staphylococcus aureus colonization increases the risk of bacteremia in hemodialysis patients: A molecular epidemiology approach with time-dependent analysis, Am. J. Infect. Control, 49, 215, 10.1016/j.ajic.2020.05.031 · DOI
  13. Tsai, 2022, Integrating complex host-pathogen immune environments into S. aureus vaccine studies, Cell Chem. Biol., 29, 730, 10.1016/j.chembiol.2022.04.003 · DOI
  14. Kobayashi, 2013, Staphylococcus aureus Protein A Promotes Immune Suppression, mBio, 4, e00764-13, 10.1128/mBio.00764-13 · DOI
  15. Forsgren, 1966, “Protein A” from S. aureus. I. Pseudo-immune reaction with human gamma-globulin, J. Immunol., 97, 822, 10.4049/jimmunol.97.6.822 · DOI · Paper page
  16. Goodyear, 2003, Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin, J. Exp. Med., 197, 1125, 10.1084/jem.20020552 · DOI · Paper page
  17. Viau, 2005, Staphylococcal Protein A Deletes B-1a and Marginal Zone B Lymphocytes Expressing Human Immunoglobulins: An Immune Evasion Mechanism, J. Immunol., 175, 7719, 10.4049/jimmunol.175.11.7719 · DOI
  18. Parcina, 2013, Pathogen-triggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus, J. Immunol., 190, 1591, 10.4049/jimmunol.1201222 · DOI
  19. Kim, 2010, Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice, J. Exp. Med., 207, 1863, 10.1084/jem.20092514 · DOI · Paper page
  20. Zhang, 1998, A second IgG-binding protein in Staphylococcus aureus, Microbiology, 144, 985, 10.1099/00221287-144-4-985 · DOI · Paper page
  21. Zhang, 1999, Staphylococcus aureus expresses a cell surface protein that binds both IgG and beta2-glycoprotein I, Microbiology, 145, 177, 10.1099/13500872-145-1-177 · DOI
  22. Tam, 2020, Targeting leukocidin-mediated immune evasion protects mice from Staphylococcus aureus bacteremia, J. Exp. Med., 217, e20190541, 10.1084/jem.20190541 · DOI
  23. Guerra, F.E., Borgogna, T.R., Patel, D.M., Sward, E.W., and Voyich, J.M. (2017). Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus. Front. Cell. Infect. Microbiol., 7. · DOI · Paper page
  24. Pidwill, 2020, The Role of Macrophages in Staphylococcus aureus Infection, Front. Immunol., 11, 620339, 10.3389/fimmu.2020.620339 · DOI · Paper page
  25. Miller, 2011, Immunity against Staphylococcus aureus cutaneous infections, Nat. Rev. Immunol., 11, 505, 10.1038/nri3010 · DOI · Paper page
  26. Brown, A.F., Murphy, A.G., Lalor, S.J., Leech, J.M., O’Keeffe, K.M., Mac Aogáin, M., O’Halloran, D.P., Lacey, K.A., Tavakol, M., and Hearnden, C.H. (2015). Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection. PLOS Pathog., 11. · DOI · Paper page
  27. Paterson, M.J., Caldera, J.R., Nguyen, C., Sharma, P., Castro, A.M., Kolar, S.L., Tsai, C.M., Limon, J.J., Becker, C.A., and Martins, G.A. (2020). Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy. PLOS Pathog., 16. · DOI
  28. Dillen, 2018, Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection, J. Clin. Investig., 128, 1026, 10.1172/JCI96481 · DOI
  29. Thammavongsa, 2015, Staphylococcal manipulation of host immune responses, Nat. Rev. Microbiol., 13, 529, 10.1038/nrmicro3521 · DOI · Paper page
  30. Xu, S.X., and McCormick, J.K. (2012). Staphylococcal superantigens in colonization and disease. Front. Cell. Infect. Microbiol., 2. · DOI · Paper page
  31. Berends, 2019, Staphylococcus aureus Impairs the Function of and Kills Human Dendritic Cells via the LukAB Toxin, mBio, 10, e01918-18, 10.1128/mBio.01918-18 · DOI
  32. Richardson, 2019, PSM Peptides From Community-Associated Methicillin-Resistant Staphylococcus aureus Impair the Adaptive Immune Response via Modulation of Dendritic Cell Subsets In Vivo, Front. Immunol., 10, 995, 10.3389/fimmu.2019.00995 · DOI
  33. Spaan, 2017, Leukocidins: Staphylococcal bi-component pore-forming toxins find their receptors, Nat. Rev. Microbiol., 15, 435, 10.1038/nrmicro.2017.27 · DOI · Paper page
  34. Schreiner, 2013, Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells, J. Immunol., 190, 3417, 10.4049/jimmunol.1202563 · DOI
  35. Mondal, S., Martinson, J.A., Ghosh, S., Watson, R., and Pahan, K. (2012). Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline. PLoS ONE, 7. · DOI
  36. Lee, 2020, Staphylococcus aureus toxin suppresses antigen-specific T cell responses J, Clin. Investig., 130, 1122, 10.1172/JCI130728 · DOI
  37. Mellergaard, 2023, Clinical Staphylococcus aureus inhibits human T-cell activity through interaction with the PD-1 receptor, mBio, 14, e1349-23, 10.1128/mbio.01349-23 · DOI
  38. Yao, 2009, PD-1 on dendritic cells impedes innate immunity against bacterial infection, Blood, 113, 5811, 10.1182/blood-2009-02-203141 · DOI · Paper page
  39. Triantafyllou, 2021, PD-1 blockade improves Kupffer cell bacterial clearance in acute liver injury, J. Clin. Investig., 131, e140196, 10.1172/JCI140196 · DOI
  40. Jurado, 2008, Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis, J. Immunol., 181, 116, 10.4049/jimmunol.181.1.116 · DOI · Paper page
  41. Lee, 2002, The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses, J. Clin. Investig., 110, 1461, 10.1172/JCI0216318 · DOI
  42. Das, 2021, Basophil-derived IL-4 promotes cutaneous Staphylococcus aureus infection, JCI Insight, 6, e149953, 10.1172/jci.insight.149953 · DOI
  43. Sanchez, 2017, O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection, Cell Host Microbe, 22, 543, 10.1016/j.chom.2017.08.008 · DOI
  44. Kak, 2023, IL-10 production by granulocytes promotes Staphylococcus aureus craniotomy infection, J. Neuroinflamm., 20, 114, 10.1186/s12974-023-02798-7 · DOI
  45. Frodermann, 2011, A Modulatory Interleukin-10 Response to Staphylococcal Peptidoglycan Prevents Th1/Th17 Adaptive Immunity to Staphylococcus aureus, J. Infect. Dis., 204, 253, 10.1093/infdis/jir276 · DOI
  46. Wang, 2000, Peptidoglycan and Lipoteichoic Acid from Staphylococcus aureus Induce Tumor Necrosis Factor Alpha, Interleukin 6 (IL-6), and IL-10 Production in Both T Cells and Monocytes in a Human Whole Blood Model, Infect. Immun., 68, 3965, 10.1128/IAI.68.7.3965-3970.2000 · DOI · Paper page
  47. Leech, 2017, IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections, J. Immunol., 198, 2352, 10.4049/jimmunol.1601018 · DOI
  48. Kelly, A.M., Leech, J.M., Doyle, S.L., and McLoughlin, R.M. (2022). Staphylococcus aureus-induced immunosuppression mediated by IL-10 and IL-27 facilitates nasal colonisation. PLoS Pathog., 18. · DOI
  49. Saraiva, 2020, Biology and therapeutic potential of interleukin-10, J. Exp. Med., 217, e20190418, 10.1084/jem.20190418 · DOI · Paper page
  50. Schultz, 2016, Opposing roles of IL-10 in acute bacterial infection, Cytokine Growth Factor Rev., 32, 17, 10.1016/j.cytogfr.2016.07.003 · DOI
  51. Redford, 2017, T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection, J. Immunol., 199, 613, 10.4049/jimmunol.1601340 · DOI
  52. Pitt, 2012, Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection, J. Immunol., 189, 4079, 10.4049/jimmunol.1201061 · DOI · Paper page
  53. Ross, 2004, Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells, Infect. Immun., 72, 1568, 10.1128/IAI.72.3.1568-1579.2004 · DOI
  54. McGuirk, 2002, Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells: A Novel Strategy for Evasion of Protective T Helper Type 1 Responses by Bordetella pertussis, J. Exp. Med., 195, 221, 10.1084/jem.20011288 · DOI · Paper page
  55. Ng, 2013, Regulation of adaptive immunity; the role of interleukin-10, Front. Immunol., 4, 129, 10.3389/fimmu.2013.00129 · DOI · Paper page
  56. Heim, 2020, Lactate production by Staphylococcus aureus biofilm inhibits HDAC11 to reprogramme the host immune response during persistent infection, Nat. Microbiol., 5, 1271, 10.1038/s41564-020-0756-3 · DOI · Paper page
  57. Gresham, 2000, Survival of Staphylococcus aureus inside neutrophils contributes to infection, J. Immunol., 164, 3713, 10.4049/jimmunol.164.7.3713 · DOI · Paper page
  58. Wilk, 2015, Manipulation of Autophagy in Phagocytes Facilitates Staphylococcus aureus Bloodstream Infection, Infect. Immun., 83, 3445, 10.1128/IAI.00358-15 · DOI
  59. Donkor, E.S., Kotey, F.C.N., Dayie, N., Duodu, S., Tetteh-Quarcoo, P.B., Osei, M.M., and Tette, E.M.A. (2019). Colonization of HIV-Infected Children with Methicillin-Resistant Staphylococcus aureus. Pathogens, 8. · DOI
  60. Popovich, 2013, Community-Associated Methicillin-Resistant Staphylococcus aureus Colonization Burden in HIV-Infected Patients, Clin. Infect. Dis., 56, 1067, 10.1093/cid/cit010 · DOI
  61. Brenchley, 2008, Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections, Blood, 112, 2826, 10.1182/blood-2008-05-159301 · DOI · Paper page
  62. Khaitan, 2010, Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection, J. Infect. Dis., 201, 843, 10.1086/651021 · DOI · Paper page
  63. Fernandez Plaza, T., Dekaban, G., and Madrenas, J. (2012). Role of IL-10 in the Immune Response to Staphylococcus aureus Nasal Carriage. [Master’s Thesis, Western University].
  64. Uebele, 2020, Staphylococcus aureus Protein A Induces Human Regulatory T Cells Through Interaction With Antigen-Presenting Cells, Front. Immunol., 11, 581713, 10.3389/fimmu.2020.581713 · DOI
  65. Hendriks, 2021, Staphylococcus aureus-Specific Tissue-Resident Memory CD4+ T Cells Are Abundant in Healthy Human Skin, Front. Immunol., 12, 642711, 10.3389/fimmu.2021.642711 · DOI
  66. Caldera, 2024, The characteristics of pre-existing humoral imprint determine efficacy of S. aureus vaccines and support alternative vaccine approaches, Cell Rep. Med., 5, 101360, 10.1016/j.xcrm.2023.101360 · DOI
  67. Meyer, 2021, A Comprehensive View on the Human Antibody Repertoire Against Staphylococcus aureus Antigens in the General Population, Front. Immunol., 12, 651619, 10.3389/fimmu.2021.651619 · DOI
  68. Wu, 2018, Prevalence of IgG and Neutralizing Antibodies against Staphylococcus aureus Alpha-Toxin in Healthy Human Subjects and Diverse Patient Populations, Infect. Immun., 86, e00671-17, 10.1128/IAI.00671-17 · DOI
  69. Radke, 2018, Hierarchy of human IgG recognition within the Staphylococcus aureus immunome, Sci. Rep., 8, 13296, 10.1038/s41598-018-31424-3 · DOI
  70. Francis, 1960, On the doctrine of original antigenic sin, Proc. Am. Philos. Soc., 104, 572
  71. Fowler, 2013, Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: A randomized trial, JAMA, 309, 1368, 10.1001/jama.2013.3010 · DOI · Paper page
  72. Francois, 2021, Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): A multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial, Lancet Infect. Dis., 21, 1313, 10.1016/S1473-3099(20)30995-6 · DOI
  73. Weems, 2006, Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia, Antimicrob. Agents Chemother., 50, 2751, 10.1128/AAC.00096-06 · DOI
  74. Teymournejad, 2023, Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy, NPJ Vaccines, 8, 3, 10.1038/s41541-022-00598-3 · DOI
  75. Hajam, I.A., Tsai, C.M., Caldera, J.R., Gonzalez, C., and Liu, G.Y. (2023, January 29–30). IL-10 production by a pathogen-specific CD4+T cell mediates failure of Staphylococcus aureus vaccines. Proceedings of the Staphylococcal Diseases, Gordon Conference, Waterville Valley, NH, USA.
  76. Ferreira, 2021, Early IL-10 promotes vasculature-associated CD4+ T cells unable to control Mycobacterium tuberculosis infection, JCI Insight, 6, e150060, 10.1172/jci.insight.150060 · DOI
  77. Smith, 2018, Interleukin-10 Directly Inhibits CD8+ T Cell Function by Enhancing N-Glycan Branching to Decrease Antigen Sensitivity, Immunity, 48, 299, 10.1016/j.immuni.2018.01.006 · DOI · Paper page
  78. Cao, 2021, Cytokines in the Immune Microenvironment Change the Glycosylation of IgG by Regulating Intracellular Glycosyltransferases, Front. Immunol., 12, 724379, 10.3389/fimmu.2021.724379 · DOI
  79. Bartsch, 2020, IgG Fc sialylation is regulated during the germinal center reaction following immunization with different adjuvants, J. Allergy Clin. Immunol., 146, 652, 10.1016/j.jaci.2020.04.059 · DOI
  80. Keener, 2017, Staphylococcus aureus Protein A Disrupts Immunity Mediated by Long-Lived Plasma Cells, J. Immunol., 198, 1263, 10.4049/jimmunol.1600093 · DOI
  81. Fiege, 2021, Mice with diverse microbial exposure histories as a model for preclinical vaccine testing, Cell Host Microbe, 29, 1815, 10.1016/j.chom.2021.10.001 · DOI
  82. Tseng, C.W., Biancotti, J.C., Berg, B.L., Gate, D., Kolar, S.L., Muller, S., Rodriguez, M.D., Rezai-Zadeh, K., Fan, X., and Beenhouwer, D.O. (2015). Increased Susceptibility of Humanized NSG Mice to Panton-Valentine Leukocidin and Staphylococcus aureus Skin Infection. PLoS Pathog., 11. · DOI
  83. Prince, 2017, Humanized Mice Exhibit Increased Susceptibility to Staphylococcus aureus Pneumonia, J. Infect. Dis., 215, 1386
  84. Redi, 2018, Staphylococcus aureus vaccine preclinical and clinical development: Current state of the art, New Microbiol., 41, 208
  85. Dadaglio, 2020, IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8+ T-cell responses, Oncoimmunology, 9, 1758606, 10.1080/2162402X.2020.1758606 · DOI
  86. Sogi, 2018, STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection, Cell Rep., 23, 1435, 10.1016/j.celrep.2018.04.003 · DOI
  87. Tsai, 2021, Adoptive Transfer of Serum Samples from Children with Invasive Staphylococcal Infection and Protection Against Staphylococcus aureus Sepsis, J. Infect. Dis., 223, 1222, 10.1093/infdis/jiaa482 · DOI

Cited by

See all 20

Metadata

Authors
Hajam, I. A., & Liu, G. Y.
Venue
Antibiotics
Publisher
MDPI AG
Published
2024-04-30
Volume
13
Issue
5
Pages
410
ISSN
2079-6382
Cited by
20
References
4
Language
en
Funders
National Institute of Health funding agency (R01AI179098, R01AI181321, R01AI144694)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Linking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures. https://app.cochat.ai/papers/10.3390/antibiotics13050410
The paper
Hajam, I. A., & Liu, G. Y. (2024). Linking S. aureus Immune Evasion Mechanisms to Staphylococcal Vaccine Failures. Antibiotics. https://doi.org/10.3390/antibiotics13050410

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.